Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMuraro, Antonella
dc.contributor.authorde Silva, Debra
dc.contributor.authorPodesta, Marcia
dc.contributor.authorAnagnostou, Aikaterini
dc.contributor.authorHalken, Susanne
dc.contributor.authorCardona, Victoria
dc.date.accessioned2025-01-21T09:36:13Z
dc.date.available2025-01-21T09:36:13Z
dc.date.issued2024-12
dc.identifier.citationMuraro A, de Silva D, Podesta M, Anagnostou A, Cardona V, Halken S, et al. 10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto. Clin Transl Allergy. 2024 Dec;14(12):e70009.
dc.identifier.issn2045-7022
dc.identifier.urihttps://hdl.handle.net/11351/12452
dc.descriptionAdrenaline; Allergy; Anaphylaxis
dc.description.abstractThis Anaphylaxis Manifesto calls on communities to prioritise 10 practical actions to improve the lives of people at risk of serious allergic reactions. The Global Allergy and Asthma European Network and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA) compiled patient-centric priorities. We used qualitative consensus methods, research evidence and feedback from over 200 patient groups, stakeholder organisations and healthcare professionals. We encourage healthcare, education and food organisations to collaborate with people at risk of serious allergic reactions to tackle safety, anxiety and financial burdens for individuals and societies. Key priorities for prevention include awareness-raising campaigns for the public and professionals, school and workplace initiatives and mandatory precautionary allergen labels on food. Priorities for improving immediate and long-term management include educating healthcare professionals, patients and schools about when and how to use adrenaline, funding two approved adrenaline devices for everyone at risk, and facilitating access to allergy specialists. Integrated care pathways should include clinical and non-clinical management options such as individualised risk assessment and quality of life assessment, self-management plans, dietetic and psychosocial support and peer support. Organisations around the world are committing to work together towards these priorities.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesClinical and Translational Allergy;14(12)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAnafilaxi - Tractament
dc.subjectAnafilaxi - Prevenció
dc.subjectAl·lèrgia
dc.subjectEducació sanitària
dc.subject.meshAnaphylaxis
dc.subject.mesh/prevention & control
dc.subject.meshPublic Health
dc.subject.meshEpinephrine
dc.subject.meshHypersensitivity
dc.title10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/clt2.70009
dc.subject.decsanafilaxia
dc.subject.decs/prevención & control
dc.subject.decseducación en salud
dc.subject.decsepinefrina
dc.subject.decshipersensibilidad
dc.relation.publishversionhttps://doi.org/10.1002/clt2.70009
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Muraro A] Padua University Hospital, Padua, Italy. [de Silva D] The Evidence Centre, London, UK. [Podesta M] European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium. [Anagnostou A] Children's Hospital, Houston, Texas, USA. Baylor College of Medicine, Houston, Texas, USA. [Cardona V] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Halken S] Hans Christian Andersen Children's Hospital and University of Southern Denmark, Odense, Denmark
dc.identifier.pmid39614094
dc.identifier.wos001369136000001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record